Endoscopy Clinical Trials

Clinical trials related to Endoscopy Procedure

Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma (EndoTEM)

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to determine whether the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon is feasible and safe. The main questions it aims to answer are: * Is the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon feasible (i.e., does it enable complete resection of the polyp)? * Is the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon safe? Participants will: * be treated with the EndoTEM system during the endoscopic submucosal dissection of polyps in the distal colon. * answere questionnaires on fecal continence and quality of life before and after the intervention. * be treated following standard clinical procedures before, during and after the endoscopic removal.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Availability of written informed consent from the patient

• Age \> 18 years

• Adenoma or early carcinoma \> 2 cm in the rectum or distal sigmoid colon with indication for endoscopic en bloc resection using endoscopic submucosal dissection

Locations
Other Locations
Germany
Universitätsklinikum Freiburg, Klinik für Innere Medizin II
NOT_YET_RECRUITING
Freiburg Im Breisgau
RKH Klinikum Ludwigsburg
NOT_YET_RECRUITING
Ludwigsburg
Robert Bosch Krankenhaus GmbH
RECRUITING
Stuttgart
Time Frame
Start Date: 2025-10-02
Estimated Completion Date: 2028-08
Participants
Target number of participants: 30
Treatments
Experimental: EndoTEM-System
Utilization of the EndoTEM system in the performance of routine endoscopic en bloc resection using endoscopic submucosal dissection.
Related Therapeutic Areas
Sponsors
Collaborators: Tuebingen Scientific Medical GmbH, Ovesco Endoscopy AG
Leads: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

This content was sourced from clinicaltrials.gov